+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stents Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • October 2023
  • Region: Global
  • Expert Market Research
  • ID: 5910846
The global Stents market size was valued at USD 12.5 billion in 2023, driven by the technological advancements across the globe. The market size is anticipated to grow at a CAGR of 5.6% during the forecast period of 2024-2032 to achieve a value of USD 20.4 billion by 2032.

Stents: Introduction

Stents are small and expandable tubes that are used to treat narrowed or weakened arteries in the body. Primarily designed to prevent blockages and restore blood flow, stents have become an essential device in cardiovascular treatments. The global stents market has evolved over the years, driven by increasing incidences of cardiovascular diseases, technological advancements, and an aging population.

Key Trends in the Global Stents Market

The global stents market, critical in addressing vascular blockages, has observed several pivotal trends recently. Firstly, the advent of bioresorbable stents has garnered attention, offering benefits over traditional metallic stents by being naturally absorbed by the body after fulfilling their function. This evolution aims to mitigate long-term complications and further interventions.

Secondly, the shift towards personalized medicine has instigated the development of stents tailored to individual patient needs, optimizing treatment outcomes. Technological strides have also manifested in the form of drug-eluting stents (DES), which release medication slowly to prevent cell proliferation, thereby reducing re-narrowing chances. This innovation has gained traction due to its enhanced efficacy compared to bare-metal stents. Furthermore, there's a growing emphasis on minimally invasive procedures, driving demand for stents in percutaneous coronary interventions.

The market also witnesses geographical expansion, with Asia Pacific showing robust growth due to rising cardiovascular ailments and expanding healthcare infrastructure. However, the market grapples with challenges like stringent regulatory scrutiny and concerns over stent thrombosis. In essence, the stents market is in a state of flux, shaped by technological innovations, patient-centric approaches, and evolving healthcare landscapes.

Global Stents Market Segmentation

Market Breakup by Product Type

  • Coronary Stents
  • Peripheral Stents
  • Neurovascular Stents
  • Stent-Related

Market Breakup by Type

  • Self-Expandable Stents
  • Balloon-Expandable Stents

Market Breakup by Material

  • Metallic Stents
  • Polymer Stents
  • Bioresorbable Stents
  • Others

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Stents Market Overview

The global stents market has cemented its position as a pivotal segment within the broader medical device industry, primarily catering to the escalating incidences of cardiovascular diseases worldwide. Primarily used as a therapeutic device for arterial blockages, the market's growth trajectory is powered by the rising geriatric population and the corresponding increase in cardiovascular conditions. A notable innovation within this sphere is the surge in the adoption of drug-eluting stents (DES), which offer enhanced efficacy in preventing arterial re-narrowing compared to their bare-metal counterparts. Moreover, bioresorbable stents, with their promise of reduced long-term complications, represent a significant advancement in stent technology.

The market also finds momentum in the increasing preference for minimally invasive surgeries and the broader acceptance of stenting procedures in emerging economies. While North America and Europe continue to be dominant players due to advanced healthcare infrastructure, the Asia-Pacific region is showcasing rapid growth owing to burgeoning healthcare needs and infrastructure development. Despite the promising landscape, the stents market grapples with challenges, including regulatory stringencies and potential post-surgical complications. Nevertheless, with continued technological innovation and research, the global stents market remains poised for sustained growth.

Global Stents Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Boston Scientific Corporation
  • BD
  • Medtronic
  • Abbott
  • Cook Medical
  • Merit Medical Systems
  • Novatech SA
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Fuji Systems Corp.
  • MICRO-TECH EUROPE
  • Vascular Concepts
  • Olympus Corporation
  • W. L. Gore & Associates Inc.
  • B. Braun Melsungen AG
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Stents Market Overview
3.1 Global Stents Market Historical Value (2017-2023)
3.2 Global Stents Market Forecast Value (2024-2032)
4 Global Stents Market Landscape
4.1 Global Stents Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Stents Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Type
4.2.3 Analysis by Applications
5 Global Stents Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Stents Market Segmentation
6.1 Global Stents Market by Product Type
6.1.1 Market Overview
6.1.2 Coronary Stents
6.1.3 Peripheral Stents
6.1.4 Neurovascular Stents
6.1.5 Stent-Related
6.2 Global Stents Market by Type
6.2.1 Market Overview
6.2.2 Self-Expandable Stents
6.2.3 Balloon-Expandable Stents
6.3 Global Stents Market by Material
6.3.1 Market Overview
6.3.2 Metallic Stents
6.3.3 Polymer Stents
6.3.4 Bioresorbable Stents
6.3.5 Others
6.4 Global Stents Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgical Centres
6.4.4 Others
6.5 Global Stents Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Stents Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Stents Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Stents Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Stents Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Stents Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Boston Scientific Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 BD
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Medtronic
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Abbott
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Cook Medical
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Merit Medical Systems
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Novatech SA
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Terumo Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 MicroPort Scientific Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Fuji Systems Corp.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 MICRO-TECH EUROPE
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Vascular Concepts
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
17.13 Olympus Corporation
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisition
17.13.5 Certifications
17.14 W. L. Gore & Associates Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisition
17.14.5 Certifications
17.15 B. Braun Melsungen AG
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisition
17.15.5 Certifications
18 Global Stents Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Boston Scientific Corporation
  • BD
  • Medtronic
  • Abbott
  • Cook Medical
  • Merit Medical Systems
  • Novatech SA
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Fuji Systems Corp.
  • MICRO-TECH EUROPE
  • Vascular Concepts
  • Olympus Corporation
  • W. L. Gore & Associates Inc.
  • B. Braun Melsungen AG

Methodology

Loading
LOADING...